The AREDS 2 study results are in:
- The only subgroup which showed a benefit of adding more lutein and zeaxanthin to the current recommended dosage, were those patients who were in the lowest quintile of dietary consumption of lutein and zeaxanthin.
- The most appropriate recommendation for most patients is incorporate sources of lutein and zeaxanthin into their diet.
- Omega 3 fatty acids were also shown to have no effect on macular degeneration, when added to the ocular vitamins.
For specific information about AREDS2, visit www.nei.nih.gov/areds2
